PHARMACOLOGICAL ACTIVITY OF THE C-TERMINAL AND N-TERMINAL DOMAINS OF SECRETORY LEUKOPROTEASE INHIBITOR IN-VITRO

被引:13
作者
MASUDA, K
KAMIMURA, T
WATANABE, K
SUGA, T
KANESAKI, M
TAKEUCHI, A
IMAIZUMI, A
SUZUKI, Y
机构
[1] Institute for Biomedical Research, Teijin Limited, Hino, Tokyo, 191
关键词
SECRETORY LEUKOPROTEASE INHIBITOR (SLPI); DOMAIN STRUCTURE; NEUTROPHIL PROTEASE; ANTI-PROTEASE; RESPIRATORY DISEASE;
D O I
10.1111/j.1476-5381.1995.tb15892.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 In order to characterize the physiological functions of the domain structure of secretory leukoprotease inhibitor (SLPI), the biological capacities of half-length SLPIs, (Ser1-Pro54)SLPI and (Asn55-Ala107)SLPI, were investigated and compared with those of full-length SLPI. 2 The activities of these inhibitors against several serine proteases were determined using synthetic chromogenic substrates. The inhibitory capacity of the C-terminal domain, (Asn55-Ala107)SLPI, was as strong as that of full-length SLPI against human neutrophil elastase (NE), cathepsin G and chymotrypsin. It possessed less trypsin inhibitory activity than intact SLPI. For the N-terminal domain of SLPI, (Ser1-Pro54)SLPI, no inhibitory activity could be detected against the serine proteases tested in this study. 3 The inhibitory activity of (Asn55-Ala107)SLPI against the proteolysis of the natural substrates elastin and collagen by NE was comparable with that of full-SLPI (elastin, IC50 = 907 +/- 31 nM for SLPI, 767 +/- 33 nM for (Asn55-Ala107)SLPI; collagen, IC50 = 862 +/- 36 nM for SLPI, 727 +/- 47 nM for (Asn55-Ala107)SLPI). 4 The binding affinities of full- and half-length SLPIs for heparin were measured by affinity column chromatography. Full-length SLPI showed high affinity for heparin while the binding capacities of both half-length SLPIs were lower. (Concentration of NaCl for elution, 0.45 M for SLPI, 0.24 M for (Ser1-Pro54)SLPI, 0.27 M for (Asn55-Ala107)SLPI). 5 The effects of full-SLPI and (Asn55-Ala107)SLPI on blood coagulation were measured using the activated partial thromboplastin time (APTT). Full-length SLPI prolonged clotting time dose-dependently (1.25, 2.5 and 5.0 mu M), whereas (Asn55-Ala107)SLPI had no effect even at the highest concentration. 6 In conclusion, the C-terminal domain of SLPI is a promising candidate for the treatment of inflammatory diseases in which participation of neutrophil proteases has been suggested.
引用
收藏
页码:883 / 888
页数:6
相关论文
共 38 条
[1]  
BEATTY K, 1980, J BIOL CHEM, V255, P3931
[2]  
BOUDIER C, 1981, J BIOL CHEM, V256, P256
[3]   EXTRACELLULAR-MATRIX INJURY DURING LUNG INFLAMMATION [J].
CAMPBELL, EJ ;
SENIOR, RM ;
WELGUS, HG .
CHEST, 1987, 92 (01) :161-167
[4]  
COHEN AB, 1983, AM REV RESPIR DIS, V127, pS2
[5]   THE ALPHA-1-ANTITRYPSIN GENE AND ITS MUTATIONS - CLINICAL CONSEQUENCES AND STRATEGIES FOR THERAPY [J].
CRYSTAL, RG ;
BRANTLY, ML ;
HUBBARD, RC ;
CURIEL, DT ;
STATES, DJ ;
HOLMES, MD .
CHEST, 1989, 95 (01) :196-208
[6]  
DEWATER R, 1986, AM REV RESPIR DIS, V133, P882
[7]   HEPARIN-INDUCED CONFORMATIONAL CHANGE AND ACTIVATION OF MUCUS PROTEINASE-INHIBITOR [J].
FALLER, B ;
MELY, Y ;
GERARD, D ;
BIETH, JG .
BIOCHEMISTRY, 1992, 31 (35) :8285-8290
[8]   TISSUE DISTRIBUTION OF ANTILEUKOPROTEASE AND LYSOZYME IN HUMANS [J].
FRANKEN, C ;
MEIJER, CJLM ;
DIJKMAN, JH .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1989, 37 (04) :493-498
[9]   CHARACTERIZATION OF THE HUMAN FACTOR-VIII PROCOAGULANT PROTEIN WITH A HETEROLOGOUS PRECIPITATING ANTIBODY [J].
FULCHER, CA ;
ZIMMERMAN, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (05) :1648-1652
[10]   RECOMBINANT SECRETORY LEUKOPROTEASE INHIBITOR AUGMENTS GLUTATHIONE LEVELS IN LUNG EPITHELIAL LINING FLUID [J].
GILLISSEN, A ;
BIRRER, P ;
MCELVANEY, NG ;
BUHL, R ;
VOGELMEIER, C ;
HOYT, RF ;
HUBBARD, RC ;
CRYSTAL, RG .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 75 (02) :825-832